Dr Jason Mellad

Jason Mellad is a scientist-entrepreneur who is passionate about translating innovative technologies into better patient outcomes.

As CEO and co-founder of Start Codon, a Cambridge based venture builder and seed fund, he aims to identify the most disruptive healthcare founders and innovations worldwide, seed fund them and leverage the exceptional resources of the Cambridge cluster to de-risk and drive the success of their start-ups.

Previously he was CEO of Cambridge Epigenetix and Business Development Manager for Horizon Discovery’s diagnostics division. He also served as an Associate at Cambridge Enterprise, which is the technology transfer office of the University of Cambridge.

Jason was awarded a Marshall Scholarship and has a PhD in Medicine from Clare College, Cambridge. He also has a BSc in Molecular Biology and Chemistry from Tulane University.